Author:
Nambiar Arjun K.,Arlandis Salvador,Bø Kari,Cobussen-Boekhorst Hanny,Costantini Elisabetta,de Heide Monica,Farag Fawzy,Groen Jan,Karavitakis Markos,Lapitan Marie Carmela,Manso Margarida,Arteaga Serenella Monagas,Riogh Aisling Nic An,O'Connor Eabhann,Omar Muhammad Imran,Peyronnet Benoit,Phé Veronique,Sakalis Vasileios I.,Sihra Néha,Tzelves Lazaros,van Poelgeest-Pomfret Mary-Lynne,van den Bos Tine W.L.,van der Vaart Huub,Harding Christopher K.
Funder
Allergan
National Institute for Health and Care Research
Astellas Pharma US
Medtronic
National and Kapodistrian University of Athens
Reference90 articles.
1. EAU guidelines on urinary incontinence in adults;Burkhard,2017
2. EAU guidelines: non-neurogenic female lower urinary tract symptoms;Harding,2021
3. FDA guidance for industry. Patient-reported outcome measures: use in medical product development to support labeling claims;US Department of Health and Human Services,2009
4. Women’s ability to assess their urinary incontinence type using the QUID as an educational tool;Farrell;Int Urogynecol J,2013
5. Long-term efficacy and safety of questionnaire-based initiation of urgency urinary incontinence treatment;Hess;Am J Obstet Gynecol,2013
Cited by
128 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献